Chemotherapy News and Research

Latest Chemotherapy News and Research

Silencing two genes can make cancer cells receptive to chemotherapy

Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to it.

4 Sep 2023

Study finds ways to improve medication adherence in breast cancer survivors

For roughly 80% of breast cancer survivors, treatment doesn't end with surgery, radiation and chemotherapy. Instead, for the next five to 10 years, doctors recommend that they take medication to block sex hormones, which can fuel tumor growth and spark recurrence.

1 Sep 2023

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not make a difference in outcomes for treating patients with an advanced form of thyroid cancer that develops from thyroid follicular cells called differentiated thyroid cancer (DTC).

1 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

New gene therapy offers hope for beta thalassemia patients

UCSF Benioff Children's Hospital Oakland provides new therapy to first patient since FDA approval.

31 Aug 2023

Universal approach could potentially expand CAR T cell therapy to all blood cancers

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer.

31 Aug 2023

ER-phagy alleviates drug-induced cardiomyopathy in cancer patients

A cell contains many specialized subunits, called organelles, that carry out important tasks such as energy generation, protein synthesis, and calcium outflux. But what happens when something goes wrong with one of the organelles?

31 Aug 2023

New discoveries about a type of immune cells could pave the way for improved immunotherapies

Fresh discoveries about a type of immune cells could give lung cancer patients a more accurate prognosis and better identify who will benefit from immunotherapies.

30 Aug 2023

New mechanism of action discovered for pulmonary distress in immunocompromised patients

When an immunocompromised person's system begins to recover and produce more white blood cells, it's usually a good thing – unless they develop a potentially deadly inflammatory condition.

30 Aug 2023

Analysis reveals limited evidence on use of cannabis products in children with cancer

A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer.

29 Aug 2023

She paid her husband’s hospital bill. A year after his death, they wanted more money.

Last summer, Eloise Reynolds paid the bill for her husband's final stay in the hospital.

29 Aug 2023

Scientific breakthrough could someday save the lives of children with rhabdomyosarcoma

"Every successful medicine has its origin story. And research like this is the soil from which new drugs are born," says Cold Spring Harbor Laboratory Professor Christopher Vakoc.

28 Aug 2023

The past, present, and future of cancer drug development

A new editorial paper was published in Oncoscience (Volume 10) on August 17, 2023, entitled, "Cancer drug development yesterday, today and tomorrow."

25 Aug 2023

Subcutaneous anchors more effective than adhesives in securing catheters

The largest study of patients with peripherally inserted central catheters (PICC) utilizing a subcutaneous anchoring securement system (SASS) ever conducted shows that using subcutaneous anchors to secure catheters is more effective than using adhesive securement devices (ASD).

25 Aug 2023

Researchers discover new therapeutic approach for neuroblastoma

Neuroblastomas are tumors of the nervous system. They can form in many places in the body and are the most common cause of cancer-related deaths in young children.

25 Aug 2023

Study shows not all adrenal carcinoma patients need mitotane after surgery

After the complete tumor resection, not all patients with an adrenocortical carcinoma require the previous standard therapy Mitotane. Professors Martin Fassnacht and Massimo Terzolo show this in a clinical trial.

25 Aug 2023

Newly published ESC Guidelines provide comprehensive overview of acute coronary syndromes

The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal.

25 Aug 2023

New drug could transform treatment of brain tumors in younger people

A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.

25 Aug 2023

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for patients with advanced gastric or gastroesophageal junction cancer that overexpressed a specific biomarker.

23 Aug 2023

Stowers researchers reveal why certain anti-cancer drugs can cause unexpected side effects

With around 90% of drugs failing to make it to market, the potential for improving efficiency within the drug development industry is clear. Drugs designed to combat cancers suffer similar rates of failure for many reasons.

23 Aug 2023

Chemotherapy News and Research

Latest Chemotherapy News and Research

Silencing two genes can make cancer cells receptive to chemotherapy

Study finds ways to improve medication adherence in breast cancer survivors

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

New gene therapy offers hope for beta thalassemia patients

Universal approach could potentially expand CAR T cell therapy to all blood cancers

ER-phagy alleviates drug-induced cardiomyopathy in cancer patients

New discoveries about a type of immune cells could pave the way for improved immunotherapies

New mechanism of action discovered for pulmonary distress in immunocompromised patients

Analysis reveals limited evidence on use of cannabis products in children with cancer

She paid her husband’s hospital bill. A year after his death, they wanted more money.

Scientific breakthrough could someday save the lives of children with rhabdomyosarcoma

The past, present, and future of cancer drug development

Subcutaneous anchors more effective than adhesives in securing catheters

Researchers discover new therapeutic approach for neuroblastoma

Study shows not all adrenal carcinoma patients need mitotane after surgery

Newly published ESC Guidelines provide comprehensive overview of acute coronary syndromes

New drug could transform treatment of brain tumors in younger people

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

Stowers researchers reveal why certain anti-cancer drugs can cause unexpected side effects

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in